1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
Global Cell Therapy Market 2017-2021

Cell Therapy Sector: Worldwide Forecast until 2021

  • September 2017
  • 118 pages
  • ID: 5096254
In this report:
In March 2017, the company raised $## million to conduct Phase III clinical trial for chronic heart failure indication.
According to the OECD, in 2016, the prevalence of diabetes ranged from less than ##% in Lithuania, Denmark, Latvia, Romania, Sweden, and Austria to over ##% in Greece, Portugal, and France.

Summary

Table of Contents

Search Inside

About Cell Therapy

Cell therapy products, which are derived from stem cells, tissues, and organs grown in laboratories, are injected into patients. The increasing number of clinical trials, government and private funding, and growing number of partnerships between firms are driving the growth of the overall cell therapy sector. Cell therapy products that are available in the sector are based on autologous and allogenic cells. The demand of cell therapy treatment is growing. This is because cell therapy products can be used for personalized treatment.

The experts estimate the worldwide cell therapy market to increase at a compound annual Growth rate of ~23.3 percent between 2017 and 2021.

What is the scope of this report?

The study describes the ongoing situation and its growth expectations of the global cell therapy sector for 2017-2021. The report includes a detailed synthesis of the market, included data from multiple sources..

The sector is segmented into the specified segments established on area:

• Americas

• Asia-Pac

• Europe, Middle East and Africa (EMEA)

The market study, World-wide Cell Therapy Sector 2017-2021, has been produced established on a comprehensive and detailed market studies with data coming from specialists of the sector. The study describes the market outlook and its growth expectations over the next years. This study also comprises conversations with top vendors operating in this segment.

Who are the market dominants?

• rise in prevalence of chronic diseases

• For a full, in-depth list, view our market report

What are the ongoing market challenges?

• High cost of clinical trials and cell therapy doses

• For a full, exhaustive list, view our market report

How is the market going?

• Proliferation of tactical alliances and royalty payments

• For a full, in-depth list, view our market report

What are the main questions answered in this report?

• What will both market value and growth rate be in 2021?

• What are the key market forecasts?

• What is driving this sector?

• What are the conditions to market growth?

• Who are the main vendors in this market environment?

If you acquire this report, you can ask for one free hour with one of our analyst. Further information is provided within the report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Stem Cell Therapy for Diabetes and Related Conditions - A Pipeline Analysis Report

Stem Cell Therapy for Diabetes and Related Conditions - A Pipeline Analysis Report

  • $ 3500
  • Industry report
  • October 2017
  • by Infiniti Research Limited

Stem cell therapy for diabetes and related conditions: An insightThe stem cell therapy for diabetes and related conditions pipeline analysis report includes ongoing clinical and non-clinical trends in ...

Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2017

Clinical Research in Hematopoietic Stem Cell Transplantation in H2, 2017

  • $ 2500
  • Industry report
  • September 2017
  • by GlobalData

Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2017SummaryGlobalData’s clinical trial report, “Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, ...

Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2017

Clinical Research in Idiopathic Pulmonary Fibrosis in H2, 2017

  • $ 2500
  • Industry report
  • October 2017
  • by GlobalData

Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2017SummaryGlobalData’s clinical trial report, “Idiopathic Pulmonary Fibrosis Global Clinical Trials Review, H2, 2017" provides an overview ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.